2011

The Spanish Clinical Research Network (CAIBER) incorporates five clinical trials led by researchers at the IDIBELL to Plan Clinical Research after obtaining a favorable resolution and excellent grades in the 2010 Intramural call. IDIBELL projects

IDIBELL has signed a collaboration agreement with the Foundation Step By Step, dedicated to the recovery of spinal injuries, to promote and support new research in the field of spinal cord injury. Step by Step

The Spanish Society of Genetics has rewarded the IDIBELL researcher in genetic applications category The Spanish Society of Genetics (SEG) and the Foundation Pryconsa have distinguished the contributions of the IDIBELL researcher, Manel Esteller, in the research on genetic application in the III Edition of the National Genetics Awards to be delivered under the XXXVIII SEG Congress, to be held from 21 to 23 September in Murcia. Manel Esteller Profile

The group of Metabolism and cellular signals at Biomedical Research Institute Alberto Sols led by Juan Manuel Zapata focuses its research on studying the regulation of TNF receptor, TRAF family of proteins and how changes in abnormal expression of these proteins may be involved in the development of leukemia or lymphoma. Zapata explained his progress in the last session of IDIBELL series of seminars held on July 8.

The year 2011 marks the International Year of Women Scientists just one hundred years after it was first awarded a Nobel Prize to a scientist, Marie Curie. In this context, on July 4 was held a meeting on the invisibility of female talent organized by ‘fem.talent’ project and Biopol’H. More information about the meeting: http://www.biopol.cat/cat/noticias/

The researcher and Professor of Nuclear Medicine at Rabdoud University, Nijmegen (Netherlands), Wim Oyen, explained its progress in the implementation of  FDG/PET imaging technique to improve the diagnosis of various diseases and facilitate the process of therapeutic decision. It was on July 1st as part of the seminars IDIBELL.

The research group of Joan X. Comella focuses on characterizing and understanding the molecular mechanisms of certain proteins that block cell death in the nervous system. This cell death is often associated with neuroinflammatory processes. “These proteins protect neurons from cell death,” explained Comella framed in a lecture in the series of seminars IDIBELL on 17 June.

On 6 June the Institute for Bioengineering of Catalonia (IBEC) presented its activities to IDIBELL biomedical researchers, as part of the official agreement of collaboration between both institutes, in a conference organized by the Biopol’H.